Search

everythinglearnresearchcommunity

for

Search:↓

Madarosis (eyebrow and eyelash loss) significantly affects quality of life for breast cancer patients on taxane-based chemotherapy.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Using certain hair products may increase breast cancer risk in black women.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Semecarpus anacardium leaf extract fights breast cancer and extends survival in mice.

Spironolactone use is not linked to an increased risk of breast cancer, but caution is advised for high-risk patients.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Examining more lymph nodes can improve survival rates in breast cancer patients without lymph node involvement.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

Certain nutraceuticals may enhance hair growth without affecting the cancer-fighting properties of tamoxifen.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Hair loss during breast cancer treatment affects each woman differently, influenced by her environment and family.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.